YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FHGU7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,135
Award facts
- Contract value 100% obligated
- $11,135.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,135.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vials. The contract, issued on December 16, 2025, with an ultimate completion date of January 8, 2026, contains no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group Inc. serves as a critical regional prime vendor contractor under the PPV-G GEN V framework, which was awarded on November 13, 2025, with a ceiling value of $499,999,999 and a performance period extending through December 31, 2036. The company's extensive pharmaceutical product portfolio encompasses branded and generic prescription medications, biologics, vaccines, and medical consumables, positioning it as a key supplier for recurring medical supply needs across military healthcare operations globally. The YF-VAX delivery order reflects the contractor's specialized capability in vaccine distribution, one of numerous product categories within its comprehensive pharmaceutical supply offerings to federal military medical facilities.
Quick answers
Who was awarded contract SPE2DR26FHGU7?
SPE2DR26FHGU7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FHGU7 worth?
The government has obligated $11,135 on SPE2DR26FHGU7.
Is contract SPE2DR26FHGU7 an order under another contract?
Yes. SPE2DR26FHGU7 is a delivery order under SPE2DR25D9244, an indefinite delivery contract.
Was contract SPE2DR26FHGU7 competed?
The extent of competition for SPE2DR26FHGU7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award